This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Athletics committee, manufacturers get dismissal of US antitrust claims over football equipment affirmed

( September 9, 2022, 22:31 GMT | Official Statement) -- MLex Summary: The National Operating Committee on Standards for Athletic Equipment and helmet manufacturers got the dismissal of Mayfield Athletics’ US antitrust claims affirmed by an appeals court. The US Court of Appeals for the Sixth Circuit determined that defendants have shown that their desire to protect their reputations and sell safe products is a legitimate business interest. “That this high standard creates barriers to entry for Mayfield illustrates only that Mayfield has elected to sell products in a market that places high regard on the safety and warranty of its products, not that the market is rife with tortious interference.” Mayfield had accused NOCSAE and the manufacturers of conspiring to exclude aftermarket or add-on products from the market for football safety equipment and accessories.See document below. ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections